Cost-effective cytomegalovirus native antigen

Presently, CMV infection is mostly controlled in immunocompromised patients by available antiviral drugs, yet it continues to maintain its role as one of the most dangerous infectious agents to the unborn infant. Primary infection is consistently associated with the presence of a virus-specific IgM antibody response. Use of NAC’s CMV purified native antigen will aid in improving serology-based assays for early detection.

www.thenativeantigencompany.com